290 related articles for article (PubMed ID: 19756415)
1. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
[TBL] [Abstract][Full Text] [Related]
2. The RPS adeno detector for diagnosing adenoviral conjunctivitis.
Sambursky R; Tauber S; Schirra F; Kozich K; Davidson R; Cohen EJ
Ophthalmology; 2006 Oct; 113(10):1758-64. PubMed ID: 17011956
[TBL] [Abstract][Full Text] [Related]
3. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
[TBL] [Abstract][Full Text] [Related]
4. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
Clement C; Capriotti JA; Kumar M; Hobden JA; Foster TP; Bhattacharjee PS; Thompson HW; Mahmud R; Liang B; Hill JM
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):339-44. PubMed ID: 20702820
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis.
Sambursky R; Trattler W; Tauber S; Starr C; Friedberg M; Boland T; McDonald M; DellaVecchia M; Luchs J
JAMA Ophthalmol; 2013 Jan; 131(1):17-22. PubMed ID: 23307204
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
[TBL] [Abstract][Full Text] [Related]
8. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
9. Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study.
Whiteside MM; Shorter ES; Margolis MS; Alvi F; Huecker JB; Than TP; Migneco MK; Harthan JS; Morettin CE; Hartwick ATE; Johnson SD; Perera CD; Gordon MO
Optom Vis Sci; 2021 May; 98(5):469-475. PubMed ID: 33973917
[TBL] [Abstract][Full Text] [Related]
10. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis.
Yazar H; Yarbag A; Balci M; Teker B; Tanyeri P
J Pak Med Assoc; 2016 Aug; 66(8):968-70. PubMed ID: 27524529
[TBL] [Abstract][Full Text] [Related]
11. A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
Ta CN; Raizman MB; Gross RD; Joshi S; Mallick S; Wang Y; Segal B
Am J Ophthalmol; 2020 Jul; 215():56-65. PubMed ID: 32222367
[TBL] [Abstract][Full Text] [Related]
12. The possibility of human adenovirus detection from the conjunctiva in asymptomatic cases during nosocomial infection.
Kaneko H; Maruko I; Iida T; Ohguchi T; Aoki K; Ohno S; Suzutani T
Cornea; 2008 Jun; 27(5):527-30. PubMed ID: 18520499
[TBL] [Abstract][Full Text] [Related]
13. Povidone iodine in the treatment of adenoviral conjunctivitis in infants.
Özen Tunay Z; Ozdemir O; Petricli IS
Cutan Ocul Toxicol; 2015 Mar; 34(1):12-5. PubMed ID: 24678746
[TBL] [Abstract][Full Text] [Related]
14. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
15. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
16. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
17. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.
Wilkins MR; Khan S; Bunce C; Khawaja A; Siriwardena D; Larkin DF
Br J Ophthalmol; 2011 Sep; 95(9):1299-303. PubMed ID: 21252084
[TBL] [Abstract][Full Text] [Related]
18. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
[TBL] [Abstract][Full Text] [Related]
19. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial.
Cagini C; Mariniello M; Messina M; Muzi A; Balducci C; Moretti A; Levorato L; Mencacci A
Int Ophthalmol; 2020 Dec; 40(12):3209-3215. PubMed ID: 32696102
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus polymerase chain reaction assay for rapid diagnosis of conjunctivitis.
Cooper RJ; Yeo AC; Bailey AS; Tullo AB
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):90-5. PubMed ID: 9888431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
